The Value of Intravenous Iodinated Contrast Media Pretesting

Kuei Yuan Hou, Wen-Yu Chien, Tszu-Hsuan Wang, Pa-Chun Wang, Shieh-Yu Lai, Yung-Cheng Wang, Chi-Jen Chen

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to assess the efficacy of intravenous iodinated contrast media pretesting and to determine whether pretesting can reduce the incidence of adverse reactions caused by administration of iodinated contrast media. We collected data on 3315 patients who had received injections of iodinated contrast media in our department from November 2005 to June 2006. The patients were divided into two groups: those in whom pretesting was performed and 1142 patients in whom pretesting was not performed. The incidence of adverse reactions after intravenous contrast media administration (including ionic and nonionic iodinated contrast media) was recorded and analyzed. In the 2173 patients with pretesting, 7 had adverse reactions during pretesting and only 1 proceeded to complete the study. This patient did not have an adverse reaction after the study. Adverse reactions occurred in 36 (1.66%) of the 2167 patients who underwent pretesting. In the 1142 patients without pretesting, adverse reactions occurred in 19 (1.66%) of these patients. The results showed no statistical difference between the two groups (p = 0.997). Pretesting patients for adverse reactions to intravenous iodinated contrast media does not decrease the incidence of peri- and postprocedure adverse reactions.
Original languageEnglish
Pages (from-to)121-124
Number of pages4
Journal中華放射線技術學雜誌
Volume33
Issue number2
Publication statusPublished - 2009

Fingerprint

Contrast Media
Incidence
Injections

Keywords

  • 含碘顯影劑
  • 檢查前測試
  • 不良反應
  • iodinated contrast media
  • ionic
  • nonionic
  • pretesting
  • adverse reaction

Cite this

Hou, K. Y., Chien, W-Y., Wang, T-H., Wang, P-C., Lai, S-Y., Wang, Y-C., & Chen, C-J. (2009). The Value of Intravenous Iodinated Contrast Media Pretesting. 中華放射線技術學雜誌, 33(2), 121-124.

The Value of Intravenous Iodinated Contrast Media Pretesting. / Hou, Kuei Yuan; Chien, Wen-Yu ; Wang, Tszu-Hsuan ; Wang, Pa-Chun; Lai, Shieh-Yu; Wang, Yung-Cheng; Chen, Chi-Jen.

In: 中華放射線技術學雜誌, Vol. 33, No. 2, 2009, p. 121-124.

Research output: Contribution to journalArticle

Hou, KY, Chien, W-Y, Wang, T-H, Wang, P-C, Lai, S-Y, Wang, Y-C & Chen, C-J 2009, 'The Value of Intravenous Iodinated Contrast Media Pretesting', 中華放射線技術學雜誌, vol. 33, no. 2, pp. 121-124.
Hou KY, Chien W-Y, Wang T-H, Wang P-C, Lai S-Y, Wang Y-C et al. The Value of Intravenous Iodinated Contrast Media Pretesting. 中華放射線技術學雜誌. 2009;33(2):121-124.
Hou, Kuei Yuan ; Chien, Wen-Yu ; Wang, Tszu-Hsuan ; Wang, Pa-Chun ; Lai, Shieh-Yu ; Wang, Yung-Cheng ; Chen, Chi-Jen. / The Value of Intravenous Iodinated Contrast Media Pretesting. In: 中華放射線技術學雜誌. 2009 ; Vol. 33, No. 2. pp. 121-124.
@article{dc1ae3f3483e40a491e0a0e41beeca0b,
title = "The Value of Intravenous Iodinated Contrast Media Pretesting",
abstract = "The purpose of this study was to assess the efficacy of intravenous iodinated contrast media pretesting and to determine whether pretesting can reduce the incidence of adverse reactions caused by administration of iodinated contrast media. We collected data on 3315 patients who had received injections of iodinated contrast media in our department from November 2005 to June 2006. The patients were divided into two groups: those in whom pretesting was performed and 1142 patients in whom pretesting was not performed. The incidence of adverse reactions after intravenous contrast media administration (including ionic and nonionic iodinated contrast media) was recorded and analyzed. In the 2173 patients with pretesting, 7 had adverse reactions during pretesting and only 1 proceeded to complete the study. This patient did not have an adverse reaction after the study. Adverse reactions occurred in 36 (1.66{\%}) of the 2167 patients who underwent pretesting. In the 1142 patients without pretesting, adverse reactions occurred in 19 (1.66{\%}) of these patients. The results showed no statistical difference between the two groups (p = 0.997). Pretesting patients for adverse reactions to intravenous iodinated contrast media does not decrease the incidence of peri- and postprocedure adverse reactions.",
keywords = "含碘顯影劑, 檢查前測試, 不良反應, iodinated contrast media, ionic, nonionic, pretesting, adverse reaction",
author = "Hou, {Kuei Yuan} and Wen-Yu Chien and Tszu-Hsuan Wang and Pa-Chun Wang and Shieh-Yu Lai and Yung-Cheng Wang and Chi-Jen Chen",
year = "2009",
language = "English",
volume = "33",
pages = "121--124",
journal = "中華放射線技術學雜誌",
issn = "1684-9418",
publisher = "中華民國醫事放射學會",
number = "2",

}

TY - JOUR

T1 - The Value of Intravenous Iodinated Contrast Media Pretesting

AU - Hou, Kuei Yuan

AU - Chien, Wen-Yu

AU - Wang, Tszu-Hsuan

AU - Wang, Pa-Chun

AU - Lai, Shieh-Yu

AU - Wang, Yung-Cheng

AU - Chen, Chi-Jen

PY - 2009

Y1 - 2009

N2 - The purpose of this study was to assess the efficacy of intravenous iodinated contrast media pretesting and to determine whether pretesting can reduce the incidence of adverse reactions caused by administration of iodinated contrast media. We collected data on 3315 patients who had received injections of iodinated contrast media in our department from November 2005 to June 2006. The patients were divided into two groups: those in whom pretesting was performed and 1142 patients in whom pretesting was not performed. The incidence of adverse reactions after intravenous contrast media administration (including ionic and nonionic iodinated contrast media) was recorded and analyzed. In the 2173 patients with pretesting, 7 had adverse reactions during pretesting and only 1 proceeded to complete the study. This patient did not have an adverse reaction after the study. Adverse reactions occurred in 36 (1.66%) of the 2167 patients who underwent pretesting. In the 1142 patients without pretesting, adverse reactions occurred in 19 (1.66%) of these patients. The results showed no statistical difference between the two groups (p = 0.997). Pretesting patients for adverse reactions to intravenous iodinated contrast media does not decrease the incidence of peri- and postprocedure adverse reactions.

AB - The purpose of this study was to assess the efficacy of intravenous iodinated contrast media pretesting and to determine whether pretesting can reduce the incidence of adverse reactions caused by administration of iodinated contrast media. We collected data on 3315 patients who had received injections of iodinated contrast media in our department from November 2005 to June 2006. The patients were divided into two groups: those in whom pretesting was performed and 1142 patients in whom pretesting was not performed. The incidence of adverse reactions after intravenous contrast media administration (including ionic and nonionic iodinated contrast media) was recorded and analyzed. In the 2173 patients with pretesting, 7 had adverse reactions during pretesting and only 1 proceeded to complete the study. This patient did not have an adverse reaction after the study. Adverse reactions occurred in 36 (1.66%) of the 2167 patients who underwent pretesting. In the 1142 patients without pretesting, adverse reactions occurred in 19 (1.66%) of these patients. The results showed no statistical difference between the two groups (p = 0.997). Pretesting patients for adverse reactions to intravenous iodinated contrast media does not decrease the incidence of peri- and postprocedure adverse reactions.

KW - 含碘顯影劑

KW - 檢查前測試

KW - 不良反應

KW - iodinated contrast media

KW - ionic

KW - nonionic

KW - pretesting

KW - adverse reaction

M3 - Article

VL - 33

SP - 121

EP - 124

JO - 中華放射線技術學雜誌

JF - 中華放射線技術學雜誌

SN - 1684-9418

IS - 2

ER -